Previous 10 | Next 10 |
2023-03-30 14:28:14 ET Shares of Terns Pharmaceuticals (NASDAQ: TERN) were up 30.7% for the week Thursday afternoon after being up as much as 37.2% for the week, according to data provided by S&P Global Market Intelligence . The healthcare stock closed at $8.92 last week...
2023-03-29 23:40:24 ET Summary NASH, or nonalcoholic steatohepatitis, is a liver inflammatory disease that can progress to fibrosis and cirrhosis. NASH is now the second leading cause of liver transplantation, and the US patient population is forecast to increase from 16 million i...
2023-03-27 17:16:26 ET Terns Pharmaceuticals press release ( NASDAQ: TERN ): Q4 GAAP EPS of -$0.29. cash, cash equivalents and marketable securities were $283.1 million Research and Development (R&D) Expenses: R&D expenses were $10.7 million and $39.6 million f...
- Announces key appointments in oncology R&D and business development functions - Cash and cash equivalents of $283 million expected to provide runway into 2026 FOSTER CITY, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the ...
2023-03-27 08:19:43 ET Terns Pharmaceuticals ( NASDAQ: TERN ) has announced the appointment of Emil Kuriakose, M.D. as chief medical officer of Terns oncology, effective May 1, 2023. After Dr. Kuriakose commences his employment at Terns, Kerry Russell, M.D., will assume th...
FOSTER CITY, Calif., March 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including ...
2023-03-21 08:13:14 ET Summary TERN has a growing pipeline of early-stage assets against validated targets. TERN's internal discovery team has been productive at developing small molecules against key targets in big markets. TERN has an important NASH readout coming in Q3 23. ...
2023-03-17 17:22:43 ET Gainers: SolarEdge Technologies ( SEDG ) +6% . SuRo Capital ( SSSS ) +5% . Cincinnati Financial Corporation ( CINF ) +5% . Northern Trust Corporation ( NTRS ) +4% . Arch Capital Group ( ACGL ) +4% . ...
Completes enrollment in Phase 2a DUET clinical trial of TERN-501 (THR-β agonist) as a treatment for NASH with top-line results expected in third quarter of 2023 On track to initiate U.S. clinical trial for TERN-701 (allosteric BCR-ABL inhibitor) in CML in second half of 2023; enr...
FOSTER CITY, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including o...
News, Short Squeeze, Breakout and More Instantly...
Terns Pharmaceuticals Inc. Company Name:
TERN Stock Symbol:
NASDAQ Market:
Terns Pharmaceuticals Inc. Website:
2024-07-20 09:30:00 ET Eli Lilly and Novo Nordisk are, for now, the undisputed champions of the market for weight-loss medicines. Thanks to the outrageous popularity of Lilly's drug Zepbound and Novo's product Wegovy, the biggest contest of the moment will go to whoever can ramp up ...
2024-07-17 00:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
FOSTER CITY, Calif., June 21, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including o...